The proteomic landscape of pancreatic ductal adenocarcinoma liver metastases identifies molecular subtypes and associations with clinical response HCH Law, D Lagundžin, EJ Clement, F Qiao, ZS Wagner, KL Krieger, ... Clinical Cancer Research 26 (5), 1065-1076, 2020 | 53 | 2020 |
Dysregulation and diagnostic potential of microRNA in Alzheimer’s disease Y Pan, R Liu, E Terpstra, Y Wang, F Qiao, J Wang, Y Tong, B Pan Journal of Alzheimer's Disease 49 (1), 1-12, 2016 | 46 | 2016 |
Therapeutic role of a cysteine precursor, OTC, in ischemic stroke is mediated by improved proteostasis in mice Y Liu, JW Min, S Feng, K Subedi, F Qiao, E Mammenga, E Callegari, ... Translational stroke research 11, 147-160, 2020 | 45 | 2020 |
FOXOs modulate proteasome activity in human-induced pluripotent stem cells of Huntington’s disease and their derived neural cells Y Liu, F Qiao, PC Leiferman, A Ross, EH Schlenker, H Wang Human Molecular Genetics 26 (22), 4416-4428, 2017 | 33 | 2017 |
Overexpression of ubiquilin-1 alleviates Alzheimer’s disease-caused cognitive and motor deficits and reduces amyloid-β accumulation in mice OO Adegoke, F Qiao, Y Liu, K Longley, S Feng, H Wang Journal of Alzheimer's Disease 59 (2), 575-590, 2017 | 32 | 2017 |
Calretinin interacts with huntingtin and reduces mutant huntingtin‐caused cytotoxicity G Dong, K Gross, F Qiao, J Ferguson, EA Callegari, K Rezvani, D Zhang, ... Journal of neurochemistry 123 (3), 437-446, 2012 | 29 | 2012 |
Enhanced proteostasis in post-ischemic stroke mouse brains by ubiquilin-1 promotes functional recovery Y Liu, F Qiao, H Wang Cellular and molecular neurobiology 37, 1325-1329, 2017 | 19 | 2017 |
The non‐peptidic δ‐opioid receptor agonist Tan‐67 mediates neuroprotection post‐ischemically and is associated with altered amyloid precursor protein expression, maturation and … JW Min, Y Liu, D Wang, F Qiao, H Wang Journal of neurochemistry 144 (3), 336-347, 2018 | 14 | 2018 |
Dexamethasone prodrug nanomedicine (ZSJ-0228) treatment significantly reduces lupus nephritis in mice without measurable side effects—A 5-month study Z Zhao, Z Jia, KW Foster, X Wei, F Qiao, H Jiang, Y Jin, G Li, N Chen, ... Nanomedicine 31, 102302, 2021 | 12 | 2021 |
Delineating the role of FANCA in glucose-stimulated insulin secretion in β cells through its protein interactome D Lagundžin, WF Hu, HCH Law, KL Krieger, F Qiao, EJ Clement, ... PloS one 14 (8), e0220568, 2019 | 12 | 2019 |
Reduced body weight gain in ubiquilin‐1 transgenic mice is associated with increased expression of energy‐sensing proteins F Qiao, KR Longley, S Feng, S Schnack, H Gao, Y Li, EH Schlenker, ... Physiological Reports 5 (8), e13260, 2017 | 10 | 2017 |
Combined alcohol exposure and KRAS mutation in human pancreatic ductal epithelial cells induces proliferation and alters subtype signatures determined by multi-omics analysis EJ Clement, HCH Law, F Qiao, D Noe, JG Trevino, NT Woods Cancers 14 (8), 1968, 2022 | 6 | 2022 |
Ctdp1 deficiency leads to early embryonic lethality in mice and defects in cell cycle progression in MEFs F Qiao, HCH Law, KL Krieger, EJ Clement, Y Xiao, SM Buckley, ... Biology Open 10 (1), bio057232, 2021 | 5 | 2021 |
Further evaluation of a novel nano‐scale gene vector for in vivo transfection of siRNA F Liu, FF Qiao, ML Tong, LL Liu, ZG Fu, B Dan, LR Lin, TC Yang, ... Journal of Cellular Biochemistry 112 (5), 1329-1336, 2011 | 2 | 2011 |
Optimization of conditions for transfection with the Sofast gene vector L Zhou, F Liu, FF Qiao, ML Tong, ZG Fu, B Dan, TC Yang, ZY Zhang Molecular Medicine Reports 4 (1), 129-135, 2011 | 1 | 2011 |
Unveiling discordant views of a novel drug's influence on cell motility from proteomics and immunofluorescence perspectives W Chen, N Woods, HCH Law, F Qiao, S Jagadesan, C Guda, R Bergan Cancer Research 84 (6_Supplement), 4121-4121, 2024 | | 2024 |
Protein structure inspired drug discovery F Qiao, A Binkowski, I Broughan, W Chen, A Natarajan, G Schiltz, ... bioRxiv, 2024.05. 17.594634, 2024 | | 2024 |
S100A14 Protein Expression in Prostate Cancer Cell Lines B Kinkor, F Qiao, K O'Neill, J Hollinger, R Bergan, W Chen | | 2023 |
Abstract 2028: Using bioinformatic analysis of proteomic data to probe novel drug mechanism of action W Chen, N Woods, F Qiao, HCH Law, S Jagadesan, C Guda, RC Bergan Cancer Research 83 (7_Supplement), 2028, 2023 | | 2023 |
Abstract 570: Dual acting bone defender agents inhibit prostate cancer-mediated bone destruction F Qiao, R Gordon, A Pattanayak, KO Neill, N Chaika, W Chen, R Rhatigan, ... Cancer Research 83 (7_Supplement), 570, 2023 | | 2023 |